Skip to content
OpenCapital
Get started

Orthofix Medical Inc. OFIX US — PP&E (Net)

Other geography segments

IT
$9.89M—
DE
$1.36M—

Similar metrics at other companies

Worthington Enterprises logo
WORUS — PP&E (Net)
$223.12M+7.4%
Luxfer Holdings logo
LXFRUS — PP&E (Net)
$23.4M-10.7%
VHI
VHIUS — PP&E (Net)
$293.3M-2.9%
Cohu logo
COHUUS — PP&E (Net)
$13.9M+2.2%
Advantage Solutions Inc. logo
ADVUS — PP&E (Net)
$114.8M+18.2%
Veeco Instruments logo
VECOUS — PP&E (Net)
$108.04M-4.4%

Other financials

Income statement

See full
Revenue$196.7M+1.6%
Gross profit$139.5M+14.7%
Operating income-$14.4M+70.5%
Net income-$20.9M+60.6%
EPS (diluted)-$0.52+61.5%

Balance sheet

See full
Cash & equivalents$120.3M+108%
Total debt$237.5M+32.3%
Total equity$435.2M-5.0%
Total assets$886.6M+7.7%

Cash flow

See full
Operating cash flow-$17.6M+4.2%
CapEx$10.7M+58.3%
Free cash flow-$28.3M-12.5%

Valuation

See full
Market cap$376.33M-7.1%
Enterprise value$493.54M-6.3%
P/S0.5×0.0×

Profitability

See full
Gross margin70.7%+3.6pp
Operating margin-5.8%-2.1pp
Net margin-7.3%-2.7pp
FCF margin-9.3%-1.7pp

Returns & leverage

See full
Return on equity-13.4%-4.6pp
Debt / equity0.5×+0.2×
Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s us — pp&e (net).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Orthofix Medical Inc.'s US — PP&E (net)?
Orthofix Medical Inc. (OFIX) reported US — PP&E (net) of $111.04M in Q1 2026.
How has Orthofix Medical Inc.'s US — PP&E (net) changed year-over-year?
Orthofix Medical Inc.'s US — PP&E (net) decreased by 4.6% year-over-year, from $116.4M to $111.04M.
What does US — PP&E (net) mean?
This metric represents the net book value of tangible assets, such as manufacturing facilities, machinery, and equipment, located within the United States segment after accounting for accumulated depreciation. It reflects the capital intensity required to support domestic operations and the company's investment in the infrastructure necessary to produce and distribute orthopedic and spine products. Monitoring this value helps investors assess the company's asset base and the efficiency of its capital investment strategy.